ArticleRheumatology (Oxford, England)2022

Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum.

Georgina Nakafero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.